Clinical Trial

REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF".

Name: REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF". — clinical trial record (NCT07390214)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: REFOCUS-AF

Recruiting

View on ClinicalTrials.gov →

Summary

This is a prospective, randomized (1:1), pilot study enrolling 200 patients with symptomatic atrial fibrillation or atrial tachycardia (AF/AT) recurrence requiring repeat ablation following a single prior PVI procedure for AF.

Trial Details

NCT Number	NCT07390214
Lead Sponsor	Cardioangiologisches Centrum Bethanien
Conditions	Atrial Fibrillation - Symptomatic
Enrollment	200 participants
Start Date	2025-12-15
Primary Completion	2028-06-30 (estimated)
Study Completion	2029-03-30 (estimated)
Updated on ClinicalTrials.gov	2026-02-05